Cargando…
Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells
BACKGROUND: Acquired treatment resistance is a significant problem in breast cancer management, and alterations in lipid metabolism have been proposed to contribute to the development of drug resistance as well as other aspects of tumor progression. The present study aimed to identify the role of ch...
Autores principales: | Zipinotti dos Santos, Diandra, Santos Guimaraes, Isabella dos, Hakeem-Sanni, Mariam F., Cochran, Blake J., Rye, Kerry-Anne, Grewal, Thomas, Hoy, Andrew J., Rangel, Leticia B. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732177/ https://www.ncbi.nlm.nih.gov/pubmed/36481936 http://dx.doi.org/10.1007/s12672-022-00598-8 |
Ejemplares similares
-
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover
por: Raftopulos, Nikki L., et al.
Publicado: (2022) -
Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010) -
Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
por: Zhang, Meng, et al.
Publicado: (2017) -
Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment
por: Henriques, Taciane Barbosa, et al.
Publicado: (2021) -
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010)